The SPDR S&P Biotech ETF (XBI) experienced a significant inflow of approximately $634.9 million, marking a 7.9% week-over-week increase in outstanding units, from 64,475,000 to 69,600,000. This change occurred recently, driving investor interest in the sector.
As of the latest trading session, XBI’s share price stands at $125.47, within its 52-week range of $66.66 to $129.12. The ETF’s price is currently compared to its 200-day moving average, providing insights into its performance trends.
